These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 10359526)

  • 1. Mutations in serines 15 and 20 of human p53 impair its apoptotic activity.
    Unger T; Sionov RV; Moallem E; Yee CL; Howley PM; Oren M; Haupt Y
    Oncogene; 1999 May; 18(21):3205-12. PubMed ID: 10359526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serine phosphorylation in the NH2 terminus of p53 facilitates transactivation.
    Mayr GA; Reed M; Wang P; Wang Y; Schweds JF; Tegtmeyer P
    Cancer Res; 1995 Jun; 55(11):2410-7. PubMed ID: 7757994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A serine 37 mutation associated with two missense mutations at highly conserved regions of p53 affect pro-apoptotic genes expression in a T-lymphoblastoid drug resistant cell line.
    Cinti C; Claudio PP; Luca AD; Cuccurese M; Howard CM; D'Esposito M; Paggi MG; Sala DL; Azzoni L; Halazonetis TD; Giordano A; Maraldi NM
    Oncogene; 2000 Oct; 19(44):5098-105. PubMed ID: 11042698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations of tumor necrosis factor alpha-responsive serine residues within the C-terminal transactivation domain of human transcription factor REL enhance its in vitro transforming ability.
    Starczynowski DT; Reynolds JG; Gilmore TD
    Oncogene; 2005 Nov; 24(49):7355-68. PubMed ID: 16027730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of p53 transcriptional activity requires ATM's kinase domain and multiple N-terminal serine residues of p53.
    Turenne GA; Paul P; Laflair L; Price BD
    Oncogene; 2001 Aug; 20(37):5100-10. PubMed ID: 11526498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of phosphorylation of rat p53 on transactivation of promoters derived from different p53 responsive genes.
    Lohrum M; Scheidtmann KH
    Oncogene; 1996 Dec; 13(12):2527-39. PubMed ID: 9000127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel human p53 mutations that are toxic to yeast can enhance transactivation of specific promoters and reactivate tumor p53 mutants.
    Inga A; Resnick MA
    Oncogene; 2001 Jun; 20(26):3409-19. PubMed ID: 11423991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wild-type p53 transactivates the KILLER/DR5 gene through an intronic sequence-specific DNA-binding site.
    Takimoto R; El-Deiry WS
    Oncogene; 2000 Mar; 19(14):1735-43. PubMed ID: 10777207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53 mutants can often transactivate promoters containing a p21 but not Bax or PIG3 responsive elements.
    Campomenosi P; Monti P; Aprile A; Abbondandolo A; Frebourg T; Gold B; Crook T; Inga A; Resnick MA; Iggo R; Fronza G
    Oncogene; 2001 Jun; 20(27):3573-9. PubMed ID: 11429705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human tumor-derived p53 proteins exhibit binding site selectivity and temperature sensitivity for transactivation in a yeast-based assay.
    Di Como CJ; Prives C
    Oncogene; 1998 May; 16(19):2527-39. PubMed ID: 9627118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutation of the serine 15 phosphorylation site of human p53 reduces the ability of p53 to inhibit cell cycle progression.
    Fiscella M; Ullrich SJ; Zambrano N; Shields MT; Lin D; Lees-Miller SP; Anderson CW; Mercer WE; Appella E
    Oncogene; 1993 Jun; 8(6):1519-28. PubMed ID: 8502477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific DNA binding by p53 is independent of mutation at serine 389, the casein kinase II site.
    Rolley N; Milner J
    Oncogene; 1994 Oct; 9(10):3067-70. PubMed ID: 8084615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COOH-terminal domain of p53 modulates p53-mediated transcriptional transactivation, cell growth, and apoptosis.
    Zhou X; Wang XW; Xu L; Hagiwara K; Nagashima M; Wolkowicz R; Zurer I; Rotter V; Harris CC
    Cancer Res; 1999 Feb; 59(4):843-8. PubMed ID: 10029073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural basis of restoring sequence-specific DNA binding and transactivation to mutant p53 by suppressor mutations.
    Suad O; Rozenberg H; Brosh R; Diskin-Posner Y; Kessler N; Shimon LJ; Frolow F; Liran A; Rotter V; Shakked Z
    J Mol Biol; 2009 Jan; 385(1):249-65. PubMed ID: 18996393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apoptosis induced by adenovirus-mediated p53 gene transfer in human glioma correlates with site-specific phosphorylation.
    Shono T; Tofilon PJ; Schaefer TS; Parikh D; Liu TJ; Lang FF
    Cancer Res; 2002 Feb; 62(4):1069-76. PubMed ID: 11861384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Papillomavirus E2 induces p53-independent apoptosis in HeLa cells.
    Desaintes C; Goyat S; Garbay S; Yaniv M; Thierry F
    Oncogene; 1999 Aug; 18(32):4538-45. PubMed ID: 10467398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plumbagin (5-hydroxy-2-methyl-1,4-naphthoquinone) induces apoptosis and cell cycle arrest in A549 cells through p53 accumulation via c-Jun NH2-terminal kinase-mediated phosphorylation at serine 15 in vitro and in vivo.
    Hsu YL; Cho CY; Kuo PL; Huang YT; Lin CC
    J Pharmacol Exp Ther; 2006 Aug; 318(2):484-94. PubMed ID: 16632641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benzo(a)pyrene increases phosphorylation of p53 at serine 392 in relation to p53 induction and cell death in MCF-7 cells.
    Tampio M; Loikkanen J; Myllynen P; Mertanen A; Vähäkangas KH
    Toxicol Lett; 2008 May; 178(3):152-9. PubMed ID: 18440733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The proline-rich region of mouse p53 influences transactivation and apoptosis but is largely dispensable for these functions.
    Edwards SJ; Hananeia L; Eccles MR; Zhang YF; Braithwaite AW
    Oncogene; 2003 Jul; 22(29):4517-23. PubMed ID: 12881708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histone deacetylase 5 is not a p53 target gene, but its overexpression inhibits tumor cell growth and induces apoptosis.
    Huang Y; Tan M; Gosink M; Wang KK; Sun Y
    Cancer Res; 2002 May; 62(10):2913-22. PubMed ID: 12019172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.